These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 16540033)

  • 41. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.
    Zohar P; Kovacic M; Brezocnik M; Podbregar M
    Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation.
    Dixen U; Joens C; Parner J; Rasmussen V; Pehrson SM; Jensen GB
    Scand Cardiovasc J; 2004 Jun; 38(3):147-51. PubMed ID: 15223712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory markers according to types of atrial fibrillation.
    Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
    Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion.
    Varounis C; Dagres N; Maounis T; Panagiotakos D; Cokkinos DV
    Europace; 2007 Aug; 9(8):633-7. PubMed ID: 17507365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
    Korantzopoulos P; Kolettis T; Siogas K; Goudevenos J
    Med Sci Monit; 2003 Sep; 9(9):RA225-9. PubMed ID: 12960937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
    Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
    Wozakowska-Kaplon B; Bartkowiak R; Janiszewska G
    Pacing Clin Electrophysiol; 2010 May; 33(5):561-5. PubMed ID: 20059712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience].
    Maffè S; Paffoni P; Perucca A; Dellavesa P; Parravicini U; Nicali R; Bielli M; Paino AM; Signorotti F; Franchetti Pardo N; Zenone F; Zanetta M
    G Ital Cardiol (Rome); 2008 Jul; 9(7):504-8. PubMed ID: 18678217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study.
    Pirat B; Atar I; Ertan C; Bozbas H; Gulmez O; Müderrisoglu H; Ozin B
    Am J Cardiol; 2007 Nov; 100(10):1552-5. PubMed ID: 17996518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prediction of atrial fibrillation recurrence after electrical cardioversion with P wave signal averaged EKG].
    Budeus M; Hennersdorf M; Perings C; Strauer BE
    Z Kardiol; 2004 Jun; 93(6):474-8. PubMed ID: 15252741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants and prognostic significance of immediate atrial fibrillation recurrence following cardioversion in patients undergoing pulmonary vein isolation.
    Husser D; Bollmann A; Kang S; Stridh M; Sornmo L; Olsson SB; Bhandari AK; Cannom DS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):119-25. PubMed ID: 15679641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion.
    Lange HW; Herrmann-Lingen C
    J Psychosom Res; 2007 Nov; 63(5):509-13. PubMed ID: 17980224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein and microalbuminuria are associated with atrial fibrillation.
    Asselbergs FW; van den Berg MP; Diercks GF; van Gilst WH; van Veldhuisen DJ
    Int J Cardiol; 2005 Jan; 98(1):73-7. PubMed ID: 15676170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
    Larsen MT; Lyngborg K; Pedersen F; Corell P
    Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation.
    Soran H; Younis N; Currie P; Silas J; Jones IR; Gill G
    QJM; 2008 Mar; 101(3):181-7. PubMed ID: 18202088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery.
    Lamm G; Auer J; Weber T; Berent R; Ng C; Eber B
    J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):51-6. PubMed ID: 16458214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
    Meurling CJ; Roijer A; Waktare JE; Holmqvist F; Lindholm CJ; Ingemansson MP; Carlson J; Stridh M; Sörnmo L; Olsson SB
    BMC Cardiovasc Disord; 2006 Mar; 6():11. PubMed ID: 16533393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation.
    Kato K; Fujimaki T; Yoshida T; Oguri M; Yajima K; Hibino T; Murohara T
    Europace; 2009 Mar; 11(3):332-7. PubMed ID: 19147485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.